Clinical Trial Update: Statin Therapy In Patients With Vasospastic Angina [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating statin therapy in patients with vasospastic angina has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vasospastic Angina

Drugs mentioned

• Statins (HMG-CoA reductase inhibitors) (statin)

Snippet

Sponsor: Seung-Jung Park | Conditions: Angina Pectoris, Variant, Statins, HMG-CoA | Phase 4 | Status: WITHDRAWN